Following an FDA Administrative advisory, Johnson & Johnson Stops Sale of its Power Morcellators Pen

Johnson & Johnson Stops Sale of its Power Morcellators Pending Increased Understanding and Re-definition of the Medical Devices by the Medical Community following a FDA Administration over the devices’ risks associated with the spread of hidden cancers during fibroid removal. Port Washington, New York (PRWEB) May 02, 2014 Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective medical devices, notes that, according to an April 30, 2014 Reuters report, Johnson & Johnson announced that it is suspending sales of its power morcellator
Contributor
PR Web
PR Web
Lanham, Maryland
Law Marketing
1.800.345.5572
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Download

Related Documents in PR Web
MCLE Sales

Categories